GERM vs. BITY
GERM (Amplify Treatments, Testing and Advancements ETF) and BITY (Amplify Bitcoin 2% Monthly Option Income ETF) are both exchange-traded funds - GERM is a Health & Biotech Equities fund tracking the Prime Treatments, Testing and Advancements Index, while BITY is a Derivative Income fund actively managed by Amplify. GERM is passively managed, while BITY is actively managed. Over the past year, GERM returned 0.00% vs -37.35% for BITY. GERM charges 0.68%/yr vs 0.65%/yr for BITY.
Performance
GERM vs. BITY - Performance Comparison
Loading charts...
Returns By Period
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BITY
- 1D
- -2.61%
- 1M
- -19.63%
- YTD
- -23.09%
- 6M
- -26.69%
- 1Y
- -37.35%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GERM vs. BITY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% |
BITY Amplify Bitcoin 2% Monthly Option Income ETF | -23.09% | -8.21% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GERM vs. BITY — Risk / Return Rank
GERM
BITY
GERM vs. BITY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Amplify Bitcoin 2% Monthly Option Income ETF (BITY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| GERM | BITY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | -0.94 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | -0.70 | — |
Drawdowns
GERM vs. BITY - Drawdown Comparison
The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum BITY drawdown of -46.36%. Use the drawdown chart below to compare losses from any high point for GERM and BITY.
Loading charts...
Drawdown Indicators
| GERM | BITY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -46.36% | +46.36% |
Max Drawdown (1Y)Largest decline over 1 year | 0.00% | -46.36% | +46.36% |
Current DrawdownCurrent decline from peak | 0.00% | -45.49% | +45.49% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -19.67% | +19.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.00% | 26.48% | -26.48% |
Volatility
GERM vs. BITY - Volatility Comparison
The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while Amplify Bitcoin 2% Monthly Option Income ETF (BITY) has a volatility of 9.68%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than BITY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GERM | BITY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 9.68% | -9.68% |
Volatility (6M)Calculated over the trailing 6-month period | 0.00% | 31.24% | -31.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 39.94% | -39.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 39.02% | -39.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 39.02% | -39.02% |
GERM vs. BITY - Expense Ratio Comparison
GERM has a 0.68% expense ratio, which is higher than BITY's 0.65% expense ratio.
Dividends
GERM vs. BITY - Dividend Comparison
GERM has not paid dividends to shareholders, while BITY's dividend yield for the trailing twelve months is around 39.66%.
| Position | TTM | 2025 |
|---|---|---|
BITY Amplify Bitcoin 2% Monthly Option Income ETF | 39.66% | 21.53% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% |
Frequently Asked Questions
BITY has higher volatility (9.68%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs BITY's -46.36%.
On 1-year performance, GERM leads with 0.00% vs -37.35% for BITY. On fees, BITY is cheaper at 0.65% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, GERM has performed better with a 0.00% return vs -37.35%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BITY is cheaper with a 0.65% expense ratio, compared with 0.68% for GERM.
BITY has the higher dividend yield at 39.66%, compared with 0.00% for GERM.
GERM is categorized as Health & Biotech Equities, while BITY is Derivative Income. Their fees differ too: 0.68% for GERM and 0.65% for BITY.
Find the right allocation for GERM and BITY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer